EVEREST ORGANICS
Back to Income Statement
|
EVEREST ORGANICS Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹7.18 Cr | ₹11 Cr | ₹0.93 Cr | ₹6.43 Cr | ₹23 Cr |
What is the latest Operating Profit of EVEREST ORGANICS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹7.18 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹0.93 Cr |
| Mar2022 | ₹6.43 Cr |
| Mar2021 | ₹23 Cr |
How is Operating Profit of EVEREST ORGANICS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.18 Cr | -34.67 | |
| Mar2024 | ₹11 Cr | 1,081.40 | |
| Mar2023 | ₹0.93 Cr | -85.53 | |
| Mar2022 | ₹6.43 Cr | -71.86 | |
| Mar2021 | ₹23 Cr | - | |
Compare Operating Profit of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹232.8 Cr | 4.8% | -20.9% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 4.8% |
-20.9% |
-12.1% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses